Doctor profile · Federal record
Dr. Steven Wallentine, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Provo, UT
- NPI 1790736122
- Accepts Medicare
- 26 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1055 N 500 W, Suite 202
Provo, UT 846043305
(801) 374-2367
fax (801) 429-8015
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- November 27, 2023
- Year of graduation
- 2000 — 26 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Utah #60986311205
- Medicaid
- UT #870281028000
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1790736122. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
78,245
Distinct HCPCS
10
Medicare allowed
$1,255,615
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 26,250 | 20 | $1 | |
J0897 |
Injection, denosumab, 1 mg | 14,520 | 166 | $23 | |
J3380 |
Injection, vedolizumab, 1 mg | 10,806 | 12 | $22 | |
J3111 |
Injection, romosozumab-aqqg, 1 mg | 7,350 | 11 | $10 | |
J9271 |
Injection, pembrolizumab, 1 mg | 5,800 | 11 | $54 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,814 | 35 | $0 | |
36415 |
Insertion of needle into vein for collection of blood sample | 1,347 | 815 | $8 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 1,170 | 492 | $7 | |
80053 |
Blood test, comprehensive group of blood chemicals | 1,017 | 463 | $10 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 850 | 23 | $1 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 1,018. This provider delivers 77× the peer median.Open Payments
Industry payments received
All-time total
$1,027
Transactions
48
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| PFIZER INC. | 12 | $161.27 | |
| EMD Serono, Inc. | 5 | $111.10 | |
| Novartis Pharmaceuticals Corporation | 5 | $106.15 | |
| Merck Sharp & Dohme LLC | 3 | $90.57 | |
| GENZYME CORPORATION | 3 | $85.06 | |
| AstraZeneca Pharmaceuticals LP | 4 | $82.21 | |
| ARRAY BIOPHARMA INC | 4 | $52.99 | |
| GlaxoSmithKline, LLC. | 3 | $48.01 | |
| Daiichi Sankyo Inc. | 2 | $47.13 | |
| Astellas Pharma US Inc | 2 | $46.86 | |
| Exelixis Inc. | 1 | $25.82 | |
| Coherus Biosciences Inc. | 1 | $23.52 | |
| Deciphera Pharmaceuticals Inc. | 1 | $21.37 | |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20.97 | |
| PUMA BIOTECHNOLOGY, INC. | 1 | $19.12 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
910
Patients
235
Total drug cost
$1,743,945
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 232 | 55 | $4,420 |
| Prednisone | Generic | 115 | 26 | $956 |
| Abiraterone Acetate | Generic | 90 | 14 | $157,236 |
| Ondansetron Hcl | Generic | 86 | 38 | $945 |
| Ondansetron Odt (Ondansetron) | Brand | 59 | 29 | $1,374 |
| Promethazine Hcl | Generic | 58 | 32 | $507 |
| Revlimid (Lenalidomide) | Brand | 42 | 0 | $676,776 |
| Gabapentin | Generic | 41 | 12 | $858 |
| Dexamethasone | Generic | 39 | 18 | $592 |
| Hydroxyurea | Generic | 30 | 0 | $1,181 |
Hospital affiliations
Frequently asked questions
What is Dr. Steven Wallentine's medical specialty?
Dr. Steven Wallentine practices Hematology & Oncology Physician in Provo, UT.
Where does Dr. Steven Wallentine practice?
Dr. Steven Wallentine practices at 1055 N 500 W, Provo, UT 846043305. Office phone: 8013742367.
What is Dr. Steven Wallentine's NPI?
Dr. Steven Wallentine's National Provider Identifier (NPI) is 1790736122, issued by NPPES.
Does Dr. Steven Wallentine accept Medicare assignment?
Yes. Dr. Steven Wallentine accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Steven Wallentine commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, denosumab, 1 mg (HCPCS J0897); Injection, vedolizumab, 1 mg (HCPCS J3380). Source: CMS Medicare Physician & Other Practitioners file.